TWD 24.2
(-0.21%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 283.86 Million TWD | 16.77% |
2022 | 243.1 Million TWD | 1.77% |
2021 | 238.88 Million TWD | -10.54% |
2020 | 267.02 Million TWD | 26.83% |
2019 | 210.53 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 289.86 Million TWD | 0.0% |
2024 Q1 | 289.86 Million TWD | 2.11% |
2023 Q3 | 283.86 Million TWD | 8.16% |
2023 FY | 283.86 Million TWD | 16.77% |
2023 Q1 | 262.44 Million TWD | 7.96% |
2023 Q2 | 262.44 Million TWD | 0.0% |
2023 Q4 | 283.86 Million TWD | 0.0% |
2022 Q3 | 243.1 Million TWD | 0.0% |
2022 Q4 | 243.1 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 52.806% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -82.625% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -573.119% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 74.099% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 82.239% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 74.096% |
Center Laboratories, Inc. | 269.22 Million TWD | -5.435% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -274.507% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | -21.323% |
InnoPharmax Inc. | 22.24 Million TWD | -1176.181% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -104.5% |
Excelsior Biopharma Inc. | 217.28 Million TWD | -30.642% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -194.111% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -123.867% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -880.725% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -145.266% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -2717.759% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -407.348% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -139.758% |